Bactrim
Bactrim Price range: $ 41,00 through $ 196,00
Back to products
Baycip
Baycip Price range: $ 42,00 through $ 113,00

Bactroban Ointment 5g

Price range: $ 55,00 through $ 200,00

Bactroban Ointment 5g is a potent topical antibiotic specifically formulated to treat a variety of bacterial skin infections. The active ingredient, mupirocin, works effectively to eliminate bacteria such as Staphylococcus aureus and Streptococcus pyogenes. This ointment is primarily used to clear up impetigo, a common and contagious skin condition characterized by sores. It is also highly effective for treating infected hair follicles and minor traumatic lesions like small cuts or abrasions that have become infected. The convenient 5g tube allows for precise application, ensuring the affected area receives targeted relief for optimal skin recovery.

Active substance: Mupirocin
SKU: Bactroban Ointment 5g Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Bactroban Ointment belongs to a class of topical antibacterial medications specifically formulated to inhibit bacterial protein synthesis. It contains mupirocin 2% as its active ingredient and is an FDA-regulated prescription medication intended for the treatment of specific primary skin infections.

Understanding proper application techniques, potential adverse effects, and precautions ensures both therapeutic efficacy and safe administration. This reference overview details the clinical characteristics, dosing guidance, and safety profile of Bactroban Ointment 5g for individual healthcare management.

Basic Information

Active Ingredient (INN) Mupirocin (2% w/w)
Dosage Form Topical Ointment (5 gram tube)
Route of Administration Cutaneous (Topical)
Primary Purpose Treatment of impetigo caused by susceptible bacteria
Prescription Status Prescription (Rx) only
Storage Requirements Store at 20°C to 25°C (68°F to 77°F)

Main Uses

Bactroban Ointment is indicated for the topical treatment of impetigo caused by susceptible strains of Staphylococcus aureus and Streptococcus pyogenes. Impetigo is a highly contagious bacterial skin infection commonly characterized by honey-colored crusted lesions, vesicles, or bullae. The ointment is specifically formulated for cutaneous application on localized skin lesions.

Off-label indications–such as secondary bacterial skin infections associated with eczema, minor abrasions, or localized wound prophylaxis–must be explicitly evaluated and determined appropriate by a licensed prescriber, as FDA approval is specific to targeted primary bacterial pathogens. It is not indicated for systemic bacterial infections, fungal skin conditions, or viral dermatological eruptions such as herpes simplex or varicella.

How the Drug Works

The active ingredient, mupirocin, works by selectively binding to bacterial isoleucyl transfer-RNA (tRNA) synthetase. This enzyme is responsible for catalyzing the formation of isoleucyl-tRNA from isoleucine and tRNA during cellular protein assembly. By inhibiting this specific enzyme, mupirocin prevents the incorporation of isoleucine into bacterial polypeptide chains, effectively halting bacterial protein synthesis and RNA synthesis.

At concentrations achieved with topical ointment application, mupirocin exhibits bactericidal activity against susceptible gram-positive organisms. Because its mechanism of action is distinct from other clinical antimicrobial classes (such as beta-lactams, macrolides, or aminoglycosides), cross-resistance with other commonly prescribed systemic antibiotics is extremely rare.

How It’s Absorbed and Eliminated

Following topical application of Bactroban Ointment to intact skin, systemic absorption of mupirocin is minimal, with measurable systemic levels generally falling below detectable thresholds (less than 0.24% systemic absorption in human trials). If mupirocin penetrates broken skin or enters systemic circulation, it undergoes rapid metabolization via ester cleavage to its principal inactive metabolite, monic acid.

Monic acid lacks antimicrobial activity and is highly bound to plasma proteins (greater than 98%). Monic acid is rapidly eliminated from the body primarily through renal excretion in urine. The elimination half-life of systemic monic acid is approximately 20 to 40 minutes. Due to negligible systemic bioavailability across intact skin, systemic drug accumulation is not expected under standard dosing regimens.

Dosing Schedule

Bactroban Ointment should be applied strictly as directed by a healthcare provider. The recommended dosage for adult and pediatric patients aged 2 months and older is a small amount of ointment–typically a thin layer equivalent to a small pea–applied directly to the affected area three times daily. Treatment duration is usually 10 days, depending on clinical response and healthcare provider instructions.

Before application, the affected skin area should be washed gently with mild soap and water and dried thoroughly. The treated area may be covered with a sterile gauze dressing if advised by a physician. Patients should avoid applying excess ointment, as over-application does not increase antimicrobial efficacy and may increase local irritation.

Practical Tips

When incorporating Bactroban Ointment into daily routines, wash hands thoroughly before and after every application to prevent spreading the infection to other areas of the body or to other individuals. Use a clean cotton swab or clean fingertip to apply the ointment gently without aggressive rubbing, which can irritate inflamed tissue.

Avoid getting the ointment into the eyes, mouth, or inside the nose; if accidental contact occurs, rinse thoroughly with cool water. If caring for a pediatric patient in a setting such as a school in Houston, ensure the treated skin area is covered with gauze if advised by a clinician, to minimize bacterial transmission to others.

Signs of Improvement

Patients can generally expect to see initial clinical improvement within 3 to 5 days after starting treatment with Bactroban Ointment. Signs that the medication is effective include a reduction in skin redness, decreasing oozing or crusting of lesions, and a reduction in localized swelling or discomfort.

Complete healing of impetigo lesions typically occurs by the end of the prescribed course. If no clinical improvement is observed after 3 to 5 days, or if the skin condition progressively worsens, treatment should be re-evaluated by a physician to confirm the underlying bacterial diagnosis or check for resistant bacterial strains.

If You Skip a Dose

If a dose of Bactroban Ointment is missed, apply the forgotten amount as soon as it is remembered. However, if it is almost time for the next scheduled application, skip the missed dose entirely and resume the normal application schedule.

Do not apply double amounts or apply extra ointment to compensate for a missed application. Consistency is critical for maintaining effective localized tissue levels of mupirocin, so establishing a routine–such as applying the medication at morning, afternoon, and bedtime–helps ensure optimal therapeutic outcomes.

Compatibility with Other Medicines

Formal drug interaction studies with systemic medications have not been extensively conducted due to the minimal systemic absorption of mupirocin when applied to intact skin. However, combining Bactroban Ointment with other topical creams, ointments, or lotions on the same skin site is not recommended unless specifically directed by a prescribing clinician.

Mixing topical products can dilute the active ingredient, alter the stability of the polyethylene glycol ointment vehicle, or change the absorption rate of mupirocin. Furthermore, applying other antimicrobial or corticosteroid ointments simultaneously to the target area may induce cutaneous irritation or unpredictable pharmacological interactions. Always inform your clinician of all current topical and systemic therapies.

Adverse Reactions

Bactroban Ointment is generally well-tolerated, but localized cutaneous reactions may occur at the site of application. The most frequently reported adverse effects include transient burning, stinging, local pain, tenderness, and pruritus (itching). In clinical trials, these local reactions occurred in less than 3% of patients.

Less common side effects include localized skin erythema (redness), cutaneous rash, dry skin, and mild edema. Extremely rare systemic hypersensitivity reactions, including anaphylaxis, hives, and contact dermatitis, have been documented. Prolonged use of antibacterial ointments may result in the overgrowth of non-susceptible organisms, including fungi. If severe irritation, rash, or skin swelling develops, discontinue use and contact a healthcare professional.

Important Precautions

Bactroban Ointment is formulated for external cutaneous use only and must not be applied to mucosal surfaces, intranasally, or in the eyes. This specific formulation contains polyethylene glycol (PEG), a vehicle component that can be absorbed through open wounds or damaged skin. Because PEG is excreted renally, caution is advised when applying Bactroban Ointment over extensive open skin areas in patients with moderate to severe renal impairment.

In pediatric populations, safety and effectiveness have been established for infants aged 2 months and older; safety in infants under 2 months has not been established. For pregnant or nursing mothers, systemic absorption across intact skin is minimal; however, usage should occur only under direct medical advice and evaluation by a healthcare provider.

Storage and Expiration

Bactroban Ointment 5g should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). Avoid exposing the tube to excessive heat, direct sunlight, or freezing temperatures.

Keep the tube tightly closed when not in use to protect the formulation from environmental contamination. Check the expiration date printed on the tube crimp and outer carton prior to use; do not use the ointment beyond the stated expiration date. Keep out of reach of children and pets.

Common Questions

What should I do if Bactroban Ointment accidentally gets into my eyes?

If Bactroban Ointment accidentally comes into contact with your eyes, rinse them thoroughly with large amounts of cool tap water or sterile saline immediately. Keep the eyelid open while flushing to remove any residual ointment vehicle. If ocular irritation, burning, redness, or vision changes persist after flushing, seek medical evaluation from a healthcare provider.

Can Bactroban Ointment be used inside the nostrils for nasal bacteria?

No, Bactroban Ointment 5g in the polyethylene glycol base is not formulated for intranasal application. A separate, specific formulation (mupirocin calcium nasal ointment) exists for nasal use. Applying standard cutaneous Bactroban Ointment to nasal mucosa can cause severe mucosal irritation and drying due to the polyethylene glycol vehicle.

Is it safe to cover the treated area with a bandage or dressing?

Yes, the treated area may be covered with a clean, sterile gauze dressing if instructed by your healthcare provider. Covering impetigo lesions can help prevent the mechanical transfer of bacteria to other body sites or to other people. Avoid using occlusive airtight dressings unless explicitly directed by your physician.

What happens if I use Bactroban Ointment for longer than 10 days?

Using Bactroban Ointment for longer than the prescribed duration increases the risk of developing resistant bacterial strains, such as mupirocin-resistant Staphylococcus aureus. Prolonged use may also disrupt normal cutaneous flora, leading to fungal superinfections or localized contact sensitization. If lesions do not clear within 10 days, consult your prescriber for re-evaluation.

Does Bactroban Ointment treat viral infections like cold sores?

No, Bactroban Ointment contains mupirocin, which is strictly an antibacterial agent. It has no pharmacological activity against viruses (such as herpes simplex virus), fungi, or yeasts. Applying an antibacterial ointment to a viral lesion will not speed healing and is not clinically indicated.

In accordance with FDA requirements. Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

20mg

Package

2 tubes

,

3 tubes

,

4 tubes

,

5 tubes

,

6 tubes

,

7 tubes

,

8 tubes

,

9 tubes

,

10 tubes

Ενεργός Ουσία